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Abstract    
   Vision  loss  in  Leber  hereditary  optic  neuropathy  (LHON,  OMIM#  535000)  is  
caused  by  pathogenic  LHON  associated  mitochondrial  DNA  (mtDNA)  variants  that  
are  often  considered  to  be  triggered  by  a  second  environmental  stress  (genotype-­
environmental  double  hit).  A  few  studies  have  demonstrated  associations  between  
the  onset  of  LHON  vision  loss  and  specific  environmental  stresses  such  as  tobacco  
or  alcohol  use.  Other  plausible   triggers,  such  as  UV  exposure   through  sunlight,  
has  not  yet  been  studied.  The  purpose  of  this  study  was  to  survey  LHON  patients’  
lifestyle   and   habits   to   investigate   the   risk   of   light   exposure   on   this   population,  
including  the  correlation  of  the  time  of  year  vision-­loss  was  triggered.  We  collected  
information   on   their   daily   smoking   habits,   alcohol   use,   and   sun   exposure   for  
months   before   and   during   the   time   of   vision   loss.   We   did   not   find   a   strong  
correlation  between  sun  exposure  and  onset  of  vision  loss,  though  we  cannot  rule  
out  a  contribution  in  precipitating  the  LHON  phenotype  since  individuals  who  lost  
their  vision  in  adulthood  reported  longer  sun  exposure,  and  more  total  exposures,  
then  individuals  who  lost  their  vision  in  youth.  This  study  contributes  to  the  growing  
body  of  literature  regarding  environmental  influences  of  LHON  blindness,  and  we  
suggest  that  UV  exposure  still  requires  further  investigation  to  understand  what,  if  
any,  role  it  may  play.  
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Introduction  
  
Leber   hereditary   optic   neuropathy   (LHON)   is   one   of   the   most   common  
mitochondrial   disorders.   The   lifetime   risk   for   visual   failure   in   individuals   with   a  
LHON-­causing  mitochondrial  DNA  is  higher  in  men  as  compared  to  women  (Van  
Senus   1963;;  Mackey   1994a;;   E.   K.   Nikoskelainen   et   al.   1987;;  Mackey   1994b).    
Ninety-­five  percent  of  LHON  carriers  will  have  one  of  three  mitochondrial  missense  
variants   in   genes   encoding   subunits   of   NADH   dehydrogenases   ND4  
(mt.11778G>A),   ND6   (mt.14484T>C),   or   ND1   (mt.3460G>A)   (Brown,   Voljavec,  
Lott,  MacDonald,  &  Wallace,  1992;;  Howell,  Kubacka,  Xu,  &  McCullough,  1991;;  
Wallace  et  al.,  1988).  Mitochondrial  NADH  dehydrogenase  (ND)  is  part  of  Complex  
I  of  the  electron  transport  chain,  important  for  the  production  of  a  proton  gradient  
and  the  reduction  of  ubiquinone  to  ubiquinol.  The  redox  reaction  at  complex  I   is  
not  100%  efficient  and  some  of  the  electrons  are  lost  as  reactive  oxygen  species  
(ROS)  (Alberts  et  al.,  2002).  Pathogenic  LHON  variants   in  complex  I   lead  to  an  
increase  in  the  generation  of  ROS  (Hofhaus  &  Attardi,  1993;;  Yen,  Lee,  Liu,  &  Wei,  
1996).   Furthermore,   the   optic   nerve   head   of   the   eye   is   extremely   energy  
demanding  as  it  is  a  meeting  point  for  nerve  axons  and  is  particularly  vulnerable  
to  energy  depletion  (Carelli,  Ross-­Cisneros,  &  Sadun,  2002).  
The   pathogenicity   of   LHON   variants   are  multifactorial;;   both   genetic   and  
environmental  factors  contribute  to  the  phenotype  (L.  Giordano  et  al.,  2015;;  Smith,  
Cooper,  Govan,  Harding,  &  Schapira,  1993).  Thus,  the  identification  of  trends  in  
patient  data  are  complicated  by  inherent  genetic  factors  that  modify  the  severity  of  
the   LHON   phenotype.   Harmful   environmental   factors   previously   investigated  
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include  smoking  (Kirkman  et  al.,  2009),  and  alcohol  consumption  (Sadun  et  al.,  
2004).  Though  less  studied,  there  are  also  case  reports  of  trauma  (Apinyawasisuk,  
Chan,   &  Arnold,   2016),   antiretroviral   therapy   and  HIV   (Shaikh,   Ta,   Basham,  &  
Mansour,  2001),  anemia  (Goyal,  Riordan-­Eva,  &  Coakes,  2004),  cyanide  exposure  
(Berninger,   von  Meyer,   Siess,   Schon,   &   Goebel,   1989),   fumes   from   a   tire   fire  
(Sanchez,   Smith,   Carelli,   Sadun,   &   Keltner,   2006),   solvents   such   as   n-­hexane  
(Carelli  et  al.,  2007),  ethambutol  medication   (Ikeda,   Ikeda,   Ikeda,  Kawakami,  &  
Mimura,   2006),   and   carbon   monoxide   intoxication   (Hwang   &   Park,   1996)  
influencing   the   LHON   phenotype.   Many   of   the   aforementioned   triggers   likely  
exacerbate   LHON   through   oxidative   stress   and/or   direct   mitochondrial   toxicity.  
Visual  recovery  reported  is  highest  for  individuals  with  the  mt.14484T>C  variant,  
however  has  been  reported   for  all   three  LHON  variants,  and  may  be  due   to  an  
alleviation   of   mitochondrial   stress   (Mashima,   Kigasawa,   Wakakura,   &   Oguchi,  
2000).  
  Light   has   been   shown   to   be   a   source   of   oxidative   stress   for   both   the  
mitochondria   and   the   mitochondria-­rich   retinal   ganglion   cells   (Osborne,  
Lascaratos,  Bron,  Chidlow,  &  Wood,  2006;;  Osborne,  Li,  Ji,  Mortiboys,  &  Jackson,  
2008).   Isolated  mitochondria   exposed   to   light   in   the   range   of   400-­760   nm   had  
reduced   mitochondrial   function,   including   redox   reactions   and   mitochondrial  
dehydrogenase   activity,   which   was   a   function   of   light   intensity   (Osborne,  
Lascaratos,  Bron,  Chidlow,  &  Wood,  2006).  Furthermore,  studies  suggest  that  light  
in   the   range   of   400-­760   nm   causes   damage   to   retinal   ganglion   cells   in   tissue  
culture   when   exposed   to   1000   Lux   of   light   for   24   and   48   hours   (1,000   Lux   is  
	   5  
equivalent  to  exposure  on  an  overcast  day,  as  compared  to  bright  sunlight,  which  
is   about   111,000   Lux)   (Osborne,   Li,   Ji,  Mortiboys,  &   Jackson,   2008).   The   light  
exposure  on  these  tissue  culture  cells  also  resulted  in  a  significant  amount  of  ROS  
species  generation  (Osborne,  Li,  Ji,  Mortiboys,  &  Jackson,  2008).  Since  light  can  
induce  retinal  damage  leading  to  the  generation  of  reactive  oxidative  species  and  
apoptosis   of   retinal   ganglion   cell   loss,   our   a   priori   hypothesis   was   that   higher  
amounts  of   light  exposure  and/or  acute   light  exposure  around   the   time  of  vison  




Recruitment  of  participants  with  LHON 
Participants  were  individuals  with  LHON  who  had  experienced  vision  loss  
and  were  invited  to  take  part  in  a  survey  designed  to  collect  information  on  smoking  
habits,  alcohol  use,  and  sun  exposure  for  months  before  and  during  the  time  of  
vision   loss.   Participants  were   recruited   internationally   by   advertisements   in   the  
monthly   LHON   Support   Group   newsletter   (https://www.lhon.org)   or   through  
postings  on  the  LHON  Support  Group  Facebook  page  (Leber's  Hereditary  Optic  
Neuropathy   (LHON)   (BLIND),   https://www.facebook.com/groups/29805437752).  
The  survey  was  provided  in  English  only.  Participants  were  also  given  the  option  
to  make  an  appointment  with  the  first  author  to  take  the  survey  over  the  phone.     
Survey  and  protocol  for  the  study  entitled  LE-­LHON  was  approved  by  the  
McMaster   Research   Ethics   Board   (Project   ID:   4852)   and   the   Sarah   Lawrence  
Internal  Review  Board.  All  procedures  followed  were  in  accordance  with  the  ethical  
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standards  of   the  responsible  committee  on  human  experimentation  (institutional  
and  national)  and  with   the  Helsinki  Declaration  of  1975,  as  revised   in  2000  (5).  
Informed   consent   was   obtained   from   all   patients   included   in   the   study.  
Respondents   could   only   complete   the   survey   after   checking   a   box   indicating  
informed   consent   to   participate.   Our   cohort   was   representative   of   the   LHON  
population,  in  which  vision  loss  tends  to  occur  between  the  ages  of  15  to  35  years  
of   age   and   the   m.11778G>A   variant   was   the   most   common   LHON   variant  
observed. 
Survey  Instrument  and  data  collection 
The   survey   was   created   and   administered   through  McMaster   University  
Limesurvey  (Schmitz,  2012).  The  survey  contained  four  sections:  Preamble  and  
Consent;;   Personal   Demographics;;   LHON   Vision   Information;;   and   Possible  
Exposures.   Qualitative   and   quantitative   questions   were   aimed   at   investigating  
possible   exposures   that   may   have   precipitated   vision   loss,   including   smoking,  
drinking,  chemicals  and  sunlight  (Sup.  Table  1).  Data  on  visual  recovery  was  also  
collected.   
Data  analysis 
Graphs   were   generated   and   statistical   analysis   was   performed   on  
GraphPad   Prism   5   and   GraphPad   Prism   8   (Swift,   1997).   World   map   was  
downloaded  from:  https://www.mytravelmap.xyz/?1.  Yearly  average  sunlight  was  
adapted   from:  
http://earth.rice.edu/mtpe/geo/geosphere/hot/energyfuture/sunlight.html   (Earth  
Forum,   Houston  Museum   of   Natural   Science;;   Data   from   the  World   Resources  
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Institute).   Hours   of   sunlight   on   the   day   of   vision   loss   was   calculated   using  
https://www.timeanddate.com/sun/usa,   and   only   if   the   participant   provided   a  
location  and  a  date  were  they  included  in  this  particular  analysis.   
Results 
Our   survey   was   completed   by   47   participants,   most   identified   as   male  
(68%),  white  (85%),  and  non-­smokers  (68%,  Fig.  1A).  The  most  common  mtDNA  
genetic  variant  was  m.11778G>A  (63.83%),  although  there  were  many  individuals  
regarded  as  having  LHON  and  did  not  state  or   report  knowing   their  pathogenic  
gene  changes  (Fig.  1B).  The  range  of  vision  loss  in  our  cohort  was  8-­69  years  old  
(Fig.   1C).   In   addition,   median   age   of   vision   loss   for   individuals   with   the  
m.11778G>A   variant   was   younger   (25   years   old),   than   the   other   variants.  
Specifically,  median  was  28  years  old  for  people  with  the  m.3460G>A  variant,  30.5  
years  old  for  people  with  the  m.14484T>C  variant  and  34  years  old  for  individuals  
with  unknown  genetic  variants  (Data  not  shown).  Males  in  the  study  had  an  earlier  
onset  of  vision  loss  (Fig.  1D).  Median  age  of  onset  for  males  was  22.5  years  old,  
whereas  the  median  for  females  was  34  years  old.  Visual  recovery  was  reported  
in   23%   of   participants   with   the   m.11778G>A   variant,   33%   in   participants   with  
m.3460G>A,  and  50%  in  participants  with  the  m.14484T>C  variant  (Sup.  Table  
2).     
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Figure   1.  Patient   demographics.   (A)   Number   of   female   and   male   participants  
(black   bars),   ethnicities   of   participants   (white   bars),   and   smoking   status   of  
participants  (grey  bars).  (B)  mtDNA  variant  distribution  for  the  participants  in  our  
study.  (C)  Rate  of  vision  loss  in  our  patient  population,  females  (black)  and  males  
(grey).    
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Figure  2.  Most  participants  lived  and  traveled  to  areas  with  moderate-­high  amount  
of   sunlight   during   or   a   few   months   prior   to   their   vision   loss.   Areas   where  
participants  lived  at  the  time  of  loss  (A)  or  traveled  to  in  the  months  leading  up  to  
the  loss,  or  during  the  loss  (B)  is  shaded  in  black.  Global  zones  of  average  yearly  
total  numbers  of  hours   in  bright  sunlight  were  shaded  with  different  colors;;  over  
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3000  hours  is  the  highest  (light  red),  2000-­3000  hours  (light  orange),  1000-­2000  
hours  (yellow)  and  less  than  1000  hours  (white).  (C)  Total  participants  travelling  at  
the  time  of  vision  loss  and  prior  to  vision  loss.  
  
We  found  that  most  participants  reported  living  in  regions  with  moderate-­
high  quantity  of  yearly  hours  of  bright  sunlight  (Fig.  2A).  Similarly,  most  traveled  in  
the  months  prior  to  a  moderate-­high  zone  as  well  (Fig.  2B).  Six  participants  (13%)  
were  travelling  at  the  time  they  experienced  vision  loss  (Fig.  2C),  but  all  travel  was  
reported  to  occur  within  the  same  zone.  Seventeen  participants  (37%)  travelled  in  
the  months  prior  to  the  loss  (Fig.  2C).  Of  these,  two  traveled  to  zones  with  higher  
average  yearly  total  number  of  hours  in  bright  sunlight.  One  travelled  from  England  
(average   1000-­2000   hours)   to   Spain   (average   2000-­3000),   and   the   other   from  
Ontario,  Canada  (average  1000-­2000  hours)  to  Sicily  (average  over  3000  hours)  
(Fig  2A,  2B).  Anecdotally,  other  participants  reported  changes  in  their  vision  after  
travel.   Travelling   to   locations  with  more   environmental   sunlight  might   be   a   risk  
factor   for   individuals  with  LHON  pathogenic  variants.  One  participant  stated,   “2  
years  ago  my  vision  worsened  again  after  a  tourist  trip  in  Portugal  (very  sunny  at  
that  moment).  I  lost  depth  sight  at  that  moment.”    
In   order   to   assess   the   possibility   of   sunlight   triggering   vision   loss,   we  
normalized  for  location,  since  different  hemispheres  experience  different  seasons.  
Historical  hours  of  sunlight  at  the  time  of  vision  loss  for  the  right  eye  and  left  eye  
slightly  differ  in  progression  (slope  for  right  eye=  0.019,  slope  for  left  eye=  -­0.009),  
however  did  not  change  with  age  (Fig.  3A).  Our  data  indicated  that  people  at  any  
age  were  not  more  or  less  likely  to  lose  their  vision  in  longer  hours  of  light  exposure  
(Fig.  3A).   
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Figure  3.  Sun  exposure  and  vision  loss  in  our  cohort.  (A)  Hours  of  sunlight  on  the  
day  vision  was  lost   in  the  right  eye  (grey  dots)  and  left  eye  (black  dots).  Line  of  
best  fit  was  calculated  through  non-­linear  regression.  (B)  Average  daily  hours  of  
sunlight  during  youth  for  individuals  who  lost  their  vision  under  20  years  old  (<20  
y)  and  over  20  years  old  (>20  y).  (C)  Average  hours  of  sunlight  during  the  months  
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(>20   y).   Months   when   vision   was   lost   for   individuals   living   in   North   America  
(international  participants  excluded  from  this  graph  to  normalize  for  seasons),  right  
eye  (D)  and  left  eye  (E).    
    
Next,  we  checked  whether  there  was  a  correlation  between  average  daily  
hours  of   sunlight   reported  during  youth  and  subsequent   visual   loss.   Individuals  
who  lost  their  vision  over  20  years  of  age  (>20  y)  tended  to  report   longer  hours  
outside  during  their  youth  than  individuals  who  lost  their  vision  before  the  age  of  
20   (<20  y,  Fig.  3B),  although   this  difference  was  not   statistically   significant   (P-­
value   right   eye   0.2187   and   left   eye   0.25014).   Average   daily   hours   of   sunlight  
reported  for  the  months  prior  to  vision  loss  was  also  higher  for  the  group  who  lost  
their  vision  over  the  age  of  20  years  old  (Fig.  3C),  but  this  too  was  not  statistically  
significant  (P-­value  for  right  eye  0.10935  and  left  eye  0.12507).  Finally,  normalizing  
for   the   individuals   exposed   to   similar   seasons   (North   America),   vision   loss  
occurred  in  almost  any  month  of  the  year  for  the  right  eye  and  left  eye  (Fig.  3D,  
3E).  Notably,   the  months  of  December,  March,  April  and  May,  tended  to  be  the  
most  common  months  that  people  reported  they  lost  their  vision  for  the  right  and  
left  eye  (Fig.  3D,  3E).    
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Figure  4.  More  participants  wear  sunglasses  post  vision   loss.  Participants  who  
wore  sunglasses   regularly  prior   to  vision   loss   (column  1),  participants   told  by  a  
medical   professional   to   wear   sunglasses   prior   to   vision   loss   (column   2)   and  
currently  wear  sunglasses  post  vision  loss  (column  3).    
  
The  habits  surrounding  sunglass  use  changed  after  the  participant  lost  their  
vision  (Fig.  4).  Sixteen  participants  were  wearing  sunglasses  routinely  prior  to  loss  
(34%),  and  now  28  wear  sunglasses  when  they  are  outside  (60%,  Fig.  4).  Only  15  
were  ever  told  by  anyone  (medical  professional  or  otherwise)  to  wear  sunglasses  
(32%),  suggesting  that  it  is  not  common  place  to  consider  this  a  contributing  factor  
to  the  condition.    
Sunglasses prior to loss
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Figure  5.  Reported  various  environmental  exposures  at   the   time  of  vision   loss.  
Shaded  grey  boxes   indicate  that   the  participant  responded  yes  to  the  assessed  
exposures.  Average  age  of  loss  for  both  right  and  left  eye,  oriented  from  youngest  
(<20  y,  A),  to  oldest  (>20  y,  B).  At  the  time  of  vision  loss;;  they  were  a  smoker  (first  
column),  exposed  to  secondhand  smoke  on  a  regular  basis  (second  column),  more  
than   20   alcoholic   beverages   per   week   on   average   or   reported   regular   binge  
drinking  (third  column),  exposed  to  toxic  chemicals  (fourth  column),  other  reported  
exposure   (fifth  column)  and  more   than  13  hours  of  sunlight   (sixth  column),  and  
started  or  completed  menopause   (last  column,  n/a   if   the  participant  was  male).  
Individuals  who  had  hormone  replacement  therapy  for  menopause  are  indicated  
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   Our  survey  also  collected  data  on  a  wide  range  environmental  exposures.  
Since  a  LHON  mtDNA  variant  is  necessary  but  not  sufficient  on  its  own  to  trigger  
the  retinal  ganglion  cell  loss,  disease  conversion  is  believed  to  occur  through  an  
assortment  of  environmental  factors.  Factors  considered  were  exposures  based  
on  studies  and  case  reports  in  the  literature,  including  being  a  smoker  (Kirkman  et  
al.,  2009),  exposure  to  secondhand  smoke  on  a  regular  basis,  consumption  of  an  
average  of  more  than  20  alcoholic  beverages  per  week  or  reported  regular  binge  
drinking  (Sadun  et  al.,  2004),  starting  or  completing  menopause  (Fantini,  Asanad,  
Karanjia,   &   Sadun,   2018),   exposed   to   toxic   chemicals   (specifically   mercury,  
turpentine,  DTT  or  MTBE  reported   in  our  cohort)   (Carelli  et  al.,  2007;;  Hwang  &  
Park,  1996),  other  reported  exposures,  and  more  than  13  hours  of  sunlight  at  the  
time  of  vision  loss.  Participants  over  20  years  old  on  average  had  two  times  the  
number  of  exposures  as   individuals  under  20  years  of  age  (Fig.  5A,  5B).  Also,  
male  participants  were  more  susceptible  to  lose  their  vision  under  the  age  of  20  
than  female  participants  (Fig.  5A,  5B). 
Though  not  a  quantifiable  exposure,  several  participants  reported  they  felt  
stress  was  a   contributing   factor.  One  participant   noted,   "In   the   year   and  a  half  
leading  up  to  becoming  LHON  affected  I  was  working  very   long  hours   in  a  very  
stressful   job,  and  as  a   result  was  not  sleeping  or  eating  well.   I  believe   that   the  
stress,  poor  nutrition  and  sleep  were  my  triggers.”  Another  individual  stated,  “The  
loss  of  vision  in  my  right  eye  occurred  after  I  gave  birth  to  my  son.  Since  then  I  
have  had  a  hysterectomy  so  have  had  changes  in  hormones,  but  not  officially  went  
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through  menopause  because  one  ovary  was  left.”  Finally,  for  another  participant  
“The  heart  surgery  caused  the  most  vision  loss.”  
Discussion 
 
Our  data  series  investigates  self-­reported  sunlight  exposures  and  several  
other  possible  environmental  triggers  for  precipitating  vision  loss  in  a  LHON  cohort.  
This  is  the  first-­time  sunlight  has  been  considered  as  a  risk  factor  for  vision  loss  in  
individuals  with  LHON,  although  it  has  long  been  hypothesized  as  a  contributor  for  
other  ocular  conditions  such  as  age-­related  macular  degeneration  (Zhou,  Zhang,  
Yu,  &  Xie,  2018)  due  to  in  vitro  studies  of  blue  light  induced  mitochondrial  death  
(del   Olmo-­Aguado,   Núñez-­Álvarez,   &   Osborne,   2016;;   Osborne   et   al.,   2008).  
Current   evidence   suggests   that   it   is   the   blue/violet   region   of   the   spectrum   that  
causes  damage  to  the  retinal  ganglion  cells  (Shang,  Wang,  Sliney,  Yang,  &  Lee,  
2017).  However,   it   is  postulated  that   light  does  not  have  a  detrimental  effect  on  
healthy  ganglion  cells,  because  the  functioning  mitochondria  is  able  to  quench  the  
ROS  (Osborne  et  al.,  2006).    
In   this   study,   participants  who  experienced  vision   loss  at   a   younger  age  
reported  lower  hours  of  sun  exposure  than  participants  who  lost  vision  at  an  older  
age  (Fig.  3B,  3C).  Interestingly,  studies  suggest  there  is  greater  UV  transmittance  
to   the   retina   in   infancy   and   childhood   than   in   adulthood   (Sanford   et   al.,   1996;;  
Werner  &  Steele,  1988),  suggesting  that  potentially  less  light  would  be  required  to  
result  in  damaging  effects  in  a  younger  population.  In  addition,  UV  absorption  by  
the   ocular   lens   increases   with   age   resulting   in   less   insult   reaching   the   retinal  
epithelia  (Dillon  &  Atherton,  1990;;  Werner  &  Steele,  1988).  We  cannot  discount  
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that  even  though  younger  individuals  were  exposed  to  less  light  on  average,  this  
exposure  may  have  been  more  damaging  to  a  compromised  ocular  system.  
Results  from  this  study  suggest  that  most  participants  with  LHON  lived  and  
travelled  to  areas  with  moderate-­high  amount  of  average  yearly  sunlight  at  the  time  
or   in  the  few  months  prior   to  their  vision   loss  (Fig.  2)  Though  this  study  did  not  
identify  any  statistically  significant  correlations  between  vision   loss  and  sunlight  
exposure,  several  participants  reported  anecdotal  evidence  of  vision  loss  during  a  
time  of  increased  sun  exposure  (e.g.  Trip  to  sunny  location).  Sun  exposure  may  
have   been   underestimated   since   we   did   not   survey   participants   about   specific  
details  of  trips  or  activities  that  occurred  prior  to  vision  loss  (e.g.  A  ski  trip,  visiting  
a  summer  home,  or  other  outdoor  activities).  Months  with  the  highest  likelihood  of  
vision  loss  for  our  cohort  was  April,  May  and  December  (Fig.  3D,  3E).  Vision  loss  
observed   in   December   possibly   correlates   with   skiing   or   travel,   and   April   with  
traveling   for   spring   break.   Furthermore,   travelling   itself   may   be   considered   a  
mitochondrial   stressor.   Altered   circadian   rhythms   may   negatively   affect  
mitochondria  (Reviewed:  Sardon  Puig,  Valera-­Alberni,  Cantó,  &  Pillon,  2018),  thus  
travelling  should  be  quantified  and  explored  as  a  possible  contributor  of  oxidative  
stress.    
Future   follow-­up   studies,   possibly   with   a   larger   sample   size,   may   be  
required   to   further   investigate   the   timing   and   surroundings   individuals   were  
exposed  to  around  the  time  of  vision  loss.  This  current  study  may  also  be  limited  
by  participants’  recall  bias,  as  their  vision  loss  may  have  occurred  many  years  in  
the  past.    
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Quantification   of   sunlight   exposure   is   also   challenged   by   multiple   other  
variables  in  an  individual’s  day-­to-­day  environment.  Geometrical  exposures,  such  
as  measuring  sun  angle,  ground  surface  albedo,  and  light  blocking  apparel,  are  
not  known  for  the  individuals  partaking  in  our  study.  UV-­B  induced  DNA  damage  
delivered  at  different  sun  angles,  whether  the  sun  is  directly  above  an  individual  
(summer   noon)   or  morning   or   afternoon  where   the   sun   irradiance   is   lower  will  
impact  absorbance  (Sliney,  2006).   In  addition,  ground  surface  reflections  play  a  
role  in  increasing  or  decreasing  the  amount  of  light  reaching  the  eye.  Even  hazy  
day  conditions  can  lead  to  wider  corneal  opening  and  may  expose  the  retina  to  
more  damage  than  bright  sunlight  (Sliney,  2006).  Reflective  ground  surfaces  such  
as  snow,  where  the  light  is  reflected  at  a  high  rate  would  be  more  damaging  than  
light   off   a   light-­absorbing   surface   like   asphalt   (Sliney,   2006).   This  may   be  why  
December  was  a  common  month  for   loss  of  vision  in  our  data  set  of   individuals  
living  in  North  America  (Fig.  3D,  3E),  though  further  studies  are  needed.    
This  study  did  find  that  participant  habits  surrounding  sunglass  use  nearly  
doubled  after  the  participant  lost  their  vision  (34%  to  60%)  (Fig.  4).  However,  it  is  
important  to  note  that  some  studies  suggest  that  sun  protective  measures  such  as  
sun-­brimmed  hats  and  sunglasses  do  not  provide  sufficient  peripheral  protection  
and  may  not  reduce  actual  UV  ocular  exposure  of  critical  parts  of  the  lens  (Sliney,  
2006).  Peripheral  light  may  be  a  risk  since  traditional  sun-­shading  devices  do  not  
block   tangential   light   and   in   shaded   areas   the   iris   of   the   eye   is  more   relaxed.  
Therefore,   it   may   be   prudent   for   health   care   professionals   to   specifically  
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recommend  “wrap  around”  sunglasses,  which  also  provide  protection  to  peripheral  
vision.  
Sources  of  light  damage  are  not  limited  to  sunlight  but  also  bright  lights  and  
blue  light-­emitting-­diode  (LEDs),  which  demonstrated  more  photochemical  injury  
as  compared  to  red  and  green  LEDs  (Shang  et  al.  2017).  Similarly,  rats  exposed  
to   red   light  at  2,000  Lux  exhibited  no  significant  difference   in  mRNA  or  protein  
expression  between  the  control  (non-­exposed  eye)  and  the  exposed  eye  (Osborne  
et  al.   2008).  Yet,   rats   that   received   the  white   light  as  an   insult   to  one  eye  had  
significant   differences   between   the   control   and   exposed   eyes   (Osborne   et   al.  
2008).  Further  suggesting  that  it  is  the  blue/violet  region  of  the  spectrum  causing  
damage  to  the  retinal  ganglion  cells.  
This  and  other  studies  suggest  that  mitochondrial  oxidative  stress  should  
be  minimalized  in    asymptomatic  LHON  carriers  (Dimitriadis  et  al.,  2014;;  Sadun  et  
al.,  2003).  In  this  study,  participants  who  experienced  vision  loss  at  an  older  age  
reported  two  times  the  number  of  exposures  than  younger  participants  (Fig.  5A,  
5B).  One  possible  explanation  is  that  older  individuals  are  more  likely  to  have  an  
accumulation   of   exposures   from   activities   such   as   smoking,   drinking   alcohol,  
workplace  exposures  etc.  than  a  younger  individual.  Another  possible  explanation  
is  that  individuals  who  lose  their  vision  later  in  life  have  genetic  modifiers  requiring  
more  insult  to  cause  disease  onset,  as  was  suggested  when  studies  found  that  the  
heaviest  smokers  had  the  latest  disease  onset  (Carelli  et  al.,  2015;;  Yu-­Wai-­man,  
Hudson,   Klopstock,   &   Chinnery,   2016).   However,   an   accumulation   of  
environmental  exposures  is  not  seen  in  all  individuals  with  LHON.  Nine  individuals  
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from  this  present  study  (four  under  20  years  of  age,  five  over  20  years  of  age)  did  
not  indicate  exposure  to  any  of  the  environmental  factors  listed  in  the  survey  (Fig.  
5).    
Exposures  specifically  listed  by  women  with  LHON  were  also  investigated.  
There  were   fifteen   total  women   (32%,  Fig.   1A)   in   this   study,  which   is   a   larger  
number  than  expected  since  only  10%  of  female  carriers  usually  experience  vision  
loss.  Four  female  participants  went  through  menopause  prior  to  or  during  vision  
loss  (Fig.  5).  Two  female  participants  had  received  hormone  replacement  therapy.    
Estrogen  has  previously  been  found  to  positively  influence  mitochondrial  subunit  
expression  (Araújo,  Beyer,  &  Arnold,  2008),  which  may  mitigate  reactive  oxidative  
species-­induced  apoptosis   in  cultured  neuronal  cells   (Valencia  &  Morán,  2004).  
Hormone  replacement  therapy  has  been  demonstrated  to  be  protective  for  female  
carriers  of  a  LHON  variant  (C.  Giordano  et  al.,  2011,  Fantini,  Asanad,  Karanjia,  &  
Sadun,  2018).  This  effect  was  noted  by  one  of  our  participants  as  well:  “I  was  on  
estrogen  after  my  hysterectomy.  I  stopped  taking  them  about  4  months  before  I  
started  having  vision  loss.  I  got  back  on  them  6  months  after  going  blind  and  within  
2  months  my  eyesight  had  improved  quite  a  bit.” 
The   complex   etiology   of   LHON  makes   it   difficult   to   determine  genotype-­
phenotype  correlations  and  to  infer  what  may  modify  disease  severity,  whether  it  
be  mitochondrial  polymorphisms,  nuclear  factors,  or  the  duration  of  environmental  
exposures   at   a   particular   time   point   during   an   individual’s   lifetime.   Further  
prospective   research   is   needed   to   encapsulate   a   wide   range   of   possible  
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environmental   and   stress-­related   exposures   across   a   large   population   of  
individuals  with  LHON.  
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Supplemental  Tables  
  
Supplemental   Table   1.   LHON   questions   on   vision   loss   (A)   and   exposure  
evaluation  (B).  
A.   LHON  Vision  Information:  Specific  questions  relating  to  your  vision.  
1.   What  date  did  you  OR  your  child  lose  vision  in  the  right  eye?  Please  be  
as  specific  as  possible  with  date,  month,  year.  
2.   At  what  AGE,  did  you  OR  your  child  lose  vision  in  the  right  eye?  
3.   Have  you  OR  your  child  had  any  visual  recovery  in  the  right  eye?  
4.   What  date  did  you  OR  your  child  lose  vision  in  the  left  eye?  Please  be  as  
specific  as  possible  with  date,  month,  year.  
5.   At  what  AGE  were  you  OR  your  child  when  vision  was  lost  in  the  left  eye?  
6.   Have  you  OR  your  child  had  any  visual  recovery  in  the  left  eye?  
7.   How  old  were  you  OR  your  child  (in  years)  when  a  formal  diagnosis  of  
Leber's  Hereditary  Optic  Neuropathy  (LHON)  was  made?  
8.   Have  you  OR  your  child  ever  had  genetic  testing?  
9.   If   done,   what   genetic   change   was   identified?   (If   unsure,   please   say  
unknown)  
10.  Which  family  members  also  are  known  to  have  LHON-­related  vision  loss?    
  
B.   Possible  Exposures:  Questions  pertaining  to  your  environment.  
1.   At  the  time  of  vision  loss  were  you  OR  your  child  a  smoker?  
2.   What  age  did  you  OR  your  child  start  smoking?  
3.   In  the  months  leading  up  to  your   initial  vision  loss,  how  often  were  you  
OR  your  child  smoking  cigarettes?  
4.   In  the  months  leading  up  to  your  initial  vision  loss,  on  average,  how  many  
cigarettes   were   you   OR   your   child   smoking   per   week   (number   on  
average)?  
5.   Prior   to   your   initial   vision   loss,   were   you   OR   your   child   exposed   to  
secondhand  smoke  on  a  regular  basis  (eg.  living  with  a  smoker  or  working  
at  a  facility  with  secondhand  smoke)?  
6.   At  the  time  of  your  OR  your  child's   initial  vision  loss  were  you  OR  they  
drinking  alcoholic  beverages?  
7.   How  old  were  you  OR  your  child  when  you  OR  they  had  your  first  alcoholic  
beverage?  
8.   In  the  months  leading  up  to  your  OR  your  child's  initial  vision  loss,  how  
many   alcoholic   beverages   were   you   OR   they   consuming   a   week   (on  
average)?  
9.   Have  you  OR  your  child  started  or  completed  menopause?  
10.  What  age  did  you  start  menopause?  
11.  During  menopause,  or  during  another  time  point,  were  you  OR  your  child  
ever  given  any  hormone  replacement  therapy  (HRT)?  
12.  Prior  to  your  initial  vision  loss,  were  you  OR  your  child  ever  been  exposed  
to  toxic  chemicals?  
13.  How  many  hours  a  day  did  you  OR  your  child  spend  outside  on  average  
as  a  youth?  
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14.  In  the  months  prior  to  your  OR  your  child's  initial  vision  loss,  how  many  
hours  was  spent  outside?  
15.  Where  were  you  OR  your  child  living  (Province  or  State,  Country)  at  the  
time  of  vision  loss?  
16.  Where  you  OR  your  child  travelling  at  the  time  of  initial  vision  loss?  
17.  In  the  months  prior  to  your  OR  your  child's  vision  loss  had  you  OR  your  
child  travelled  anywhere?  
18.  If  yes,  where  did  you  OR  your  child  travel  and  for  how  long?  
19.  Prior  to  your  OR  your  child's  initial  vision  loss,  did  you  OR  they  usually  
wear  sun  glasses  when  outside?  
20.  Have  you  OR  your  child  ever  been  told  to  protect  your  OR  their  eyes  from  
sunlight  exposure?  
21.  Do  you  OR  your  child  normally  wear  sun  glasses  when  outside?    
  
  
Supplemental   Table   2.  Reported   partial   recovery   of   vision   loss   in   our   LHON  
cohort.    
  
